ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,864, issued on Feb. 17, was assigned to INTERVET INC. (Rahway, N.J.).
"Caninized antibodies to human CTLA-4" was invented by Mohamad Morsey (Omaha, Neb.), Yuanzheng Zhang (Somerset, N.J.) and Ian Tarpey (St. Ives, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides caninized anti-human CTLA-4 antibodies that have specific sequences and a high binding affinity for canine CTLA-4. The invention also relates to use of these antibodies in the treatment of cancer in canines and other companion animals."
The patent was filed on July 15, 2020, under Application No. 17/626,242.
*For further information, including ima...